an=79; bn=78;cn=27; dn=7
FEV1, forced expiratory volume in 1 second; ICS, inhaled
corticosteroids; OCS, oral corticosteroids.
Percentages are given for valid population
Table 2. Non-severe exacerbations, pulmonary function and use of
healthcare resources / absenteeism before and after one year of
treatment with omalizumab (n=80)